Press Release: Neuronetics : Neuronetics Provides Business Update and Issues 2025 Guidance
MALVERN, Pa., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the "Company") today announced preliminary fourth quarter and full year 2024 revenue and issued 2025 financial guidance.
Read full article »
Neuronetics is a Pennsylvania-based medical device company that develops non-invasive therapeutic systems for the treatment of chronic psychiatric and neurological disorders.
Read more